In this chapter, we summarize the latest findings in the field of immuno-oncology of women cancers, particularly ovarian and breast tumors. We describe the relationship between immune parameters and clinical outcomes by evaluating the contribution of different players of the tumor microenvironment, with a particular focus on different immune cell subsets and their essential role during the development of the disease, the response to standard chemotherapy, and to emerging immunotherapeutic approaches. By reviewing the molecular and genetic features of ovarian and breast cancer subtypes, we report on the multitude of factors influencing treatment outcome, with a particular interest on the possible influence of the immune system (i.e., tumor infiltrating lymphocytes, T cells, regulatory T cells, myeloid-derived suppressor cells, dendritic cells, macrophages, B cells, tumor-associated neutrophils). Finally, we discuss emerging immune targets and novel therapeutic modalities that are likely to profoundly influence clinical outcome and prognosis of breast and ovarian cancers in the next future.

The Immune Landscape in Women Cancers / Timperi, E.; Vissio, E.; Marchio, C.; Romano, E.. - (2020), pp. 215-249. - CANCER TREATMENT AND RESEARCH. [10.1007/978-3-030-38862-1_8].

The Immune Landscape in Women Cancers

Timperi E.
Primo
Writing – Review & Editing
;
2020

Abstract

In this chapter, we summarize the latest findings in the field of immuno-oncology of women cancers, particularly ovarian and breast tumors. We describe the relationship between immune parameters and clinical outcomes by evaluating the contribution of different players of the tumor microenvironment, with a particular focus on different immune cell subsets and their essential role during the development of the disease, the response to standard chemotherapy, and to emerging immunotherapeutic approaches. By reviewing the molecular and genetic features of ovarian and breast cancer subtypes, we report on the multitude of factors influencing treatment outcome, with a particular interest on the possible influence of the immune system (i.e., tumor infiltrating lymphocytes, T cells, regulatory T cells, myeloid-derived suppressor cells, dendritic cells, macrophages, B cells, tumor-associated neutrophils). Finally, we discuss emerging immune targets and novel therapeutic modalities that are likely to profoundly influence clinical outcome and prognosis of breast and ovarian cancers in the next future.
2020
Cancer Treatment and Research
Breast cancer; Dendritic cells (DC); Immunotherapy; Macrophages; Myeloid-derived suppressor cells (MDSC); Neoadjuvant therapy (NACT); Ovarian cancer; Regulatory T cells (Tregs); T cells; Tumor infiltrating lymphocytes (TILs); B-Lymphocytes; Breast Neoplasms; Dendritic Cells; Female; Humans; Immunotherapy; Macrophages; Neutrophils; Ovarian Neoplasms; Prognosis; T-Lymphocytes, Regulatory; Tumor Microenvironment; Lymphocytes, Tumor-Infiltrating
02 Pubblicazione su volume::02a Capitolo o Articolo
The Immune Landscape in Women Cancers / Timperi, E.; Vissio, E.; Marchio, C.; Romano, E.. - (2020), pp. 215-249. - CANCER TREATMENT AND RESEARCH. [10.1007/978-3-030-38862-1_8].
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1651310
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact